These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6851961)

  • 21. Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes.
    Vajda FJ; Merory J; Bladin PF
    Proc Aust Assoc Neurol; 1975; 12():61-4. PubMed ID: 1215397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.
    Lambie DG; Johnson RH; Nanda RN; Shakir RA
    Lancet; 1976 Aug; 2(7982):386-9. PubMed ID: 73851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum phenytoin levels with different brands.
    Kishore K; Jailakhani BL; Sharma JN; Ahuja GK
    Indian J Physiol Pharmacol; 1986; 30(2):171-6. PubMed ID: 3546122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
    Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
    J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cimetidine/diazepam interaction.
    Klotz U; Anttila VJ; Reimann T
    Lancet; 1979 Sep; 2(8144):699. PubMed ID: 90793
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting individual phenytoin serum levels of patients seen in a private office practice.
    Robinson FC; Warner RN; Gonzalez MA
    Neurology; 1981 Jun; 31(6):761-3. PubMed ID: 7195494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phenytoin intoxication and serum level].
    Beier R; Zschiesche M; Cammann R
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):414-23. PubMed ID: 704704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cimetidine interaction with warfarin.
    Hetzel D; Birkett D; Miners J
    Lancet; 1979 Sep; 2(8143):639. PubMed ID: 90304
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma anticonvulsant concentrations during pregnancy.
    Lander CM; Edwards VE; Eadie MJ; Tyrer JH
    Neurology; 1977 Feb; 27(2):128-31. PubMed ID: 556828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
    Neuvonen PJ; Bardy A; Lehtovaara R
    Br J Clin Pharmacol; 1979 Jul; 8(1):37-41. PubMed ID: 552295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid and blood thiamine concentrations in phenytoin-treated epileptics.
    Botez MI; Joyal C; Maag U; Bachevalier J
    Can J Neurol Sci; 1982 Feb; 9(1):37-9. PubMed ID: 7093823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased clearance of phenytoin with cimetidine.
    Algozzine GJ; Stewart RB; Springer PK
    Ann Intern Med; 1981 Aug; 95(2):244-5. PubMed ID: 7258891
    [No Abstract]   [Full Text] [Related]  

  • 34. Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy.
    Norell E; Lilienberg G; Gamstorp I
    Eur Neurol; 1975; 13(3):232-44. PubMed ID: 807479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.
    Shakir RA; Johnson RH; Lambie DG; Melville ID; Nanda RN
    Epilepsia; 1981 Feb; 22(1):27-33. PubMed ID: 6781888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone-marrow depression with cimetidine plus carmustine.
    Selker RG; Moore P; Lodolce D
    N Engl J Med; 1978 Oct; 299(15):834. PubMed ID: 692572
    [No Abstract]   [Full Text] [Related]  

  • 37. [Phenytoin serum concentration in epileptic patients: influence of therapeutic and physiological factors (author's transl)].
    May T; Stenzel E; Rambeck B
    Nervenarzt; 1982 May; 53(5):291-6. PubMed ID: 7099314
    [No Abstract]   [Full Text] [Related]  

  • 38. Adrenal cortex hormones in male epileptic patients before and during a 2-year phenytoin treatment.
    Ostrowska Z; Buntner B; Rościszewska D; Guz I
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):374-8. PubMed ID: 3129539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Serum-phenytoin and body-weight.
    Ayers GJ; Goudie JH; Burnett D
    Lancet; 1976 Apr; 1(7963):809-10. PubMed ID: 56625
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phenytoin kinetics in toxic serum levels].
    Beier R; Zschiesche M; Franke G
    Psychiatr Neurol Med Psychol (Leipz); 1983 Aug; 35(8):471-8. PubMed ID: 6635035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.